To include your compound in the COVID-19 Resource Center, submit it here.

Seaside Therapeutics, Roche deal

Roche and Seaside partnered to develop disease modifying treatments for fragile X syndrome and autism spectrum disorders. Seaside

Read the full 183 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE